Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Debt / NOTE 2.875% 2/1
-
Market price (% of par)
-
110.61%
-
Total 13F principal
-
$228,151,727
-
Principal change
-
-$3,317,880
-
Total reported market value
-
$268,334,805
-
Number of holders
-
16
-
Value change
-
-$4,306,575
-
Number of buys
-
8
-
Number of sells
-
7
Institutional Holders of COLLEGIUM PHARMACEUTICAL INC - NOTE 2.875% 2/1 as of Q2 2024
As of 30 Jun 2024,
COLLEGIUM PHARMACEUTICAL INC - NOTE 2.875% 2/1 was held by
16 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$228,151,727
in principal (par value) of the bond.
The largest 10 bondholders included
Linden Advisors LP, WHITEBOX ADVISORS LLC, WOLVERINE ASSET MANAGEMENT LLC, STEELHEAD PARTNERS LLC, LAZARD ASSET MANAGEMENT LLC, BNP PARIBAS FINANCIAL MARKETS, HIGHBRIDGE CAPITAL MANAGEMENT LLC, BlueCrest Capital Management Ltd, Jefferies Financial Group Inc., and SSI INVESTMENT MANAGEMENT LLC.
This page lists
16
institutional bondholders reporting positions
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.